Fmr LLC Has $1.07 Billion Holdings in Humana Inc. (NYSE:HUM)

Fmr LLC lifted its position in Humana Inc. (NYSE:HUM) by 23.4% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,388,859 shares of the insurance provider’s stock after purchasing an additional 643,291 shares during the quarter. Fmr LLC owned 2.81% of Humana worth $1,073,387,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of HUM. Creative Financial Designs Inc. ADV lifted its holdings in shares of Humana by 244.0% during the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 61 shares during the period. CarsonAllaria Wealth Management Ltd. lifted its stake in Humana by 111.4% during the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after purchasing an additional 39 shares during the period. Atwood & Palmer Inc. acquired a new stake in Humana during the third quarter valued at approximately $29,000. Ashton Thomas Securities LLC bought a new stake in shares of Humana in the 3rd quarter valued at approximately $31,000. Finally, Your Advocates Ltd. LLP raised its holdings in shares of Humana by 81.8% in the 3rd quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock worth $32,000 after buying an additional 45 shares in the last quarter. 92.38% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

HUM has been the topic of a number of analyst reports. Leerink Partners cut Humana from an “outperform” rating to a “market perform” rating and lowered their price target for the company from $400.00 to $250.00 in a research report on Wednesday, October 2nd. Barclays lifted their price target on shares of Humana from $250.00 to $253.00 and gave the company an “equal weight” rating in a report on Thursday, October 31st. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $395.00 price objective on shares of Humana in a research note on Tuesday, October 1st. Leerink Partnrs downgraded Humana from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Finally, Royal Bank of Canada decreased their price target on Humana from $400.00 to $265.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 8th. Twenty investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, Humana currently has a consensus rating of “Hold” and a consensus price target of $315.86.

Humana Stock Up 0.4 %

NYSE:HUM opened at $296.83 on Thursday. The stock’s fifty day simple moving average is $275.91 and its 200-day simple moving average is $330.00. The firm has a market capitalization of $35.74 billion, a P/E ratio of 26.29, a P/E/G ratio of 2.40 and a beta of 0.52. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $526.47.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.48 by $0.68. The company had revenue of $29.30 billion during the quarter, compared to analyst estimates of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. Equities research analysts expect that Humana Inc. will post 15.86 earnings per share for the current year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be issued a $0.885 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 annualized dividend and a yield of 1.19%. Humana’s dividend payout ratio (DPR) is presently 31.36%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.